{"id":14152,"date":"2024-06-25T12:00:00","date_gmt":"2024-06-25T12:00:00","guid":{"rendered":"https:\/\/ubc.com\/?p=14152"},"modified":"2025-05-15T21:38:02","modified_gmt":"2025-05-15T21:38:02","slug":"ubc-thread-expand-siteplus-optimize-evidence-generation","status":"publish","type":"post","link":"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/","title":{"rendered":"UBC and Thread Expand SitePlus Offering and Active Studies with BioPharma Sponsors to Optimize Evidence Generation"},"content":{"rendered":"\n

United BioSource LLC (UBC), a leading provider of evidence development solutions, and Thread\u00ae, a leading decentralized research, electronic clinical outcome assessment (eCOA) and consulting services provider, today announced the expansion of their SitePlus solution. This joint offering, the outcome of a successful six-year working relationship, has provided early recruitment and retention success for biopharma customers since its March 2023 launch. UBC and Thread have now expanded the solution to offer additional central site services and technology features for both post-approval research and Phase II\/III interventional clinical trials.<\/p>\n\n\n\n

SitePlus provides a next-generation research model that can be initiated from initial study design and launch or added alongside any ongoing Phase II \u2013 IV study nationwide. SitePlus offers a central site model which extends the reach of sites and widens the addressable patient population. The solution leverages a centralized technology platform to accelerate patient recruitment, facilitate home health engagement, securely capture data, and enable superior patient retention.<\/p>\n\n\n\n

SitePlus combines UBC\u2019s industry leading late-stage research solutions with Thread\u2019s technology to empower central site study designs focused on patients while improving the research experience for all participating sites. It further enables biopharma sponsors to contract with UBC as a central research center inclusive of investigator and study coordinating center concierge support services. SitePlus connects UBC\u2019s central principal investigator, home health, and patient coordinating center expertise with Thread\u2019s unified technology platform and consulting services for data capture, virtual visits, and optimized patient engagement.<\/p>\n\n\n\n

\u201cStudy designs that rely exclusively on brick-and-mortar site models can benefit from the enhancements SitePlus offers to help meet their patient enrollment and retention goals,\u201d said Bekki Bracken Brown, President & Chief Executive Officer, UBC. \u201cStudies leveraging a hybrid approach have seen success in reaching a more representative patient population, faster, and maintaining patient engagement. The Thread technology platform supports our central site offering by enabling a more flexible approach to patient recruitment and engagement and strengthens the return on evidence generation for our customers. \u201c<\/p>\n\n\n\n

UBC and Thread\u2019s enterprise collaboration continues to enrich UBC\u2019s modernized study designs and eCOA solutions that enable patient-centered research studies to be conducted in the clinic, in the home, and on-the-go.<\/p>\n\n\n\n

\u201cBased on strong early results with SitePlus for our joint customers, we are excited to expand its features to offer solutions in both interventional and post-approval research studies,\u201d said Thread Co-Founder and CEO John Reites. \u201cWe appreciate UBC\u2019s continued partnership and the feedback from our biopharma customers to add more value to this important innovative offering\u2019s market growth.\u201d<\/p>\n\n\n\n

Learn more about SitePlus at www.AddSitePlus.com<\/a><\/p>\n\n\n\n

\n\n\n\n

About UBC<\/strong><\/p>\n\n\n\n

United BioSource LLC (UBC) is the leading provider of evidence development solutions with expertise in uniting evidence and access. UBC helps biopharma mitigate risk, address product hurdles, and demonstrate safety, efficacy, and value under real-world conditions. Underpinned by our scientific expertise, data and analytics, and innovative technologies, we offer our customers flexible solutions generating the relevant real-world data necessary to make more informed decisions earlier, meet stakeholder requirements, and, ultimately, drive better patient outcomes. For additional information, visit\u00a0www.ubc.com<\/a>.<\/p>\n\n\n\n

MEDIA INQUIRIES<\/strong><\/p>\n\n\n\n

Amber Frasketi<\/p>\n\n\n\n

Head of Marketing & Strategic Communications<\/p>\n\n\n\n

UBC<\/p>\n\n\n\n

Phone: +1 215.588.8423<\/p>\n\n\n\n

Email: amber.frasketi@ubc.com<\/p>\n\n\n\n

About Thread<\/strong>\u202f\u202f <\/p>\n\n\n\n

Thread\u2019s\u00ae purpose is to leverage its decentralized research platform to enable studies for everyone, everywhere. The company\u2019s uniquely combined clinical research technology and consulting services help life science organizations to design, operate, and scale next-generation research studies and electronic clinical outcome assessments (eCOA) programs for participants, sites, and study teams. Through its comprehensive platform and scientific expertise, Thread empowers studies to be accessible, efficient, and centered on the patient. Backed by health care investors Water Street Healthcare Partners and JLL Partners, Thread is recognized as a leader by Everest Group\u2019s Decentralized Clinical Trial Product PEAK Matrix\u00ae Assessment 2021\/2022 and positioned in the Leader’s Category of the 2022 IDC MarketScape for R&D Decentralized Clinical Trial Technology Solutions Vendor Assessment 2022. Visit\u202fThreadresearch.com<\/a>\u202fto learn more.\u202f\u202f\u202f <\/p>\n\n\n\n

Media Contact:<\/strong>\u202f\u202f <\/p>\n\n\n\n

Les Yates <\/p>\n\n\n\n

Thread\u202f <\/p>\n\n\n\n

Media@Threadresearch.com<\/a>  <\/p>\n","protected":false},"excerpt":{"rendered":"

This augments the central site model with additional research services and tech to widen recruitment and improves site and patient experience.<\/p>\n","protected":false},"author":12,"featured_media":14153,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-14152","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press"],"acf":[],"yoast_head":"\nUBC & Thread Expand SitePlus Offering for Biopharma - UBC<\/title>\n<meta name=\"description\" content=\"This augments the central site model with additional research services and tech to widen recruitment and improves site and patient experience.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UBC and Thread Expand SitePlus Offering and Active Studies with BioPharma Sponsors to Optimize Evidence Generation\" \/>\n<meta property=\"og:description\" content=\"This augments the central site model with additional research services and tech to widen recruitment and improves site and patient experience.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/\" \/>\n<meta property=\"og:site_name\" content=\"UBC\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-25T12:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-15T21:38:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ubc.com\/wp-content\/uploads\/2024\/06\/GettyImages-1141304089.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2121\" \/>\n\t<meta property=\"og:image:height\" content=\"1414\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"HDMZ Dev\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"HDMZ Dev\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/\"},\"author\":{\"name\":\"HDMZ Dev\",\"@id\":\"https:\/\/ubc.com\/#\/schema\/person\/6c108e8902cd351f2e70ea0e7ba78b14\"},\"headline\":\"UBC and Thread Expand SitePlus Offering and Active Studies with BioPharma Sponsors to Optimize Evidence Generation\",\"datePublished\":\"2024-06-25T12:00:00+00:00\",\"dateModified\":\"2025-05-15T21:38:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/\"},\"wordCount\":687,\"commentCount\":32,\"publisher\":{\"@id\":\"https:\/\/ubc.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ubc.com\/wp-content\/uploads\/2024\/06\/GettyImages-1141304089.jpg\",\"articleSection\":[\"Press\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/\",\"url\":\"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/\",\"name\":\"UBC & Thread Expand SitePlus Offering for Biopharma - UBC\",\"isPartOf\":{\"@id\":\"https:\/\/ubc.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ubc.com\/wp-content\/uploads\/2024\/06\/GettyImages-1141304089.jpg\",\"datePublished\":\"2024-06-25T12:00:00+00:00\",\"dateModified\":\"2025-05-15T21:38:02+00:00\",\"description\":\"This augments the central site model with additional research services and tech to widen recruitment and improves site and patient experience.\",\"breadcrumb\":{\"@id\":\"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/#primaryimage\",\"url\":\"https:\/\/ubc.com\/wp-content\/uploads\/2024\/06\/GettyImages-1141304089.jpg\",\"contentUrl\":\"https:\/\/ubc.com\/wp-content\/uploads\/2024\/06\/GettyImages-1141304089.jpg\",\"width\":2121,\"height\":1414,\"caption\":\"Global network connection concept. Big data visualization. Social network communication in the global computer networks. Internet technology. Business. Science. Vector illustration.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ubc.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"UBC and Thread Expand SitePlus Offering and Active Studies with BioPharma Sponsors to Optimize Evidence Generation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ubc.com\/#website\",\"url\":\"https:\/\/ubc.com\/\",\"name\":\"UBC\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/ubc.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ubc.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ubc.com\/#organization\",\"name\":\"UBC\",\"url\":\"https:\/\/ubc.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ubc.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ubc.com\/wp-content\/uploads\/2023\/07\/Layer_1.png\",\"contentUrl\":\"https:\/\/ubc.com\/wp-content\/uploads\/2023\/07\/Layer_1.png\",\"width\":188,\"height\":50,\"caption\":\"UBC\"},\"image\":{\"@id\":\"https:\/\/ubc.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ubc.com\/#\/schema\/person\/6c108e8902cd351f2e70ea0e7ba78b14\",\"name\":\"HDMZ Dev\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ubc.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/da56f7401fb06d5e5f91ff06deaef82cd94d0acfef072f55663628117c7c4ac2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/da56f7401fb06d5e5f91ff06deaef82cd94d0acfef072f55663628117c7c4ac2?s=96&d=mm&r=g\",\"caption\":\"HDMZ Dev\"},\"url\":\"https:\/\/ubc.com\/news\/author\/hdmzdev\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"UBC & Thread Expand SitePlus Offering for Biopharma - UBC","description":"This augments the central site model with additional research services and tech to widen recruitment and improves site and patient experience.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/","og_locale":"en_US","og_type":"article","og_title":"UBC and Thread Expand SitePlus Offering and Active Studies with BioPharma Sponsors to Optimize Evidence Generation","og_description":"This augments the central site model with additional research services and tech to widen recruitment and improves site and patient experience.","og_url":"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/","og_site_name":"UBC","article_published_time":"2024-06-25T12:00:00+00:00","article_modified_time":"2025-05-15T21:38:02+00:00","og_image":[{"width":2121,"height":1414,"url":"https:\/\/ubc.com\/wp-content\/uploads\/2024\/06\/GettyImages-1141304089.jpg","type":"image\/jpeg"}],"author":"HDMZ Dev","twitter_card":"summary_large_image","twitter_misc":{"Written by":"HDMZ Dev","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/#article","isPartOf":{"@id":"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/"},"author":{"name":"HDMZ Dev","@id":"https:\/\/ubc.com\/#\/schema\/person\/6c108e8902cd351f2e70ea0e7ba78b14"},"headline":"UBC and Thread Expand SitePlus Offering and Active Studies with BioPharma Sponsors to Optimize Evidence Generation","datePublished":"2024-06-25T12:00:00+00:00","dateModified":"2025-05-15T21:38:02+00:00","mainEntityOfPage":{"@id":"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/"},"wordCount":687,"commentCount":32,"publisher":{"@id":"https:\/\/ubc.com\/#organization"},"image":{"@id":"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/#primaryimage"},"thumbnailUrl":"https:\/\/ubc.com\/wp-content\/uploads\/2024\/06\/GettyImages-1141304089.jpg","articleSection":["Press"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/","url":"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/","name":"UBC & Thread Expand SitePlus Offering for Biopharma - UBC","isPartOf":{"@id":"https:\/\/ubc.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/#primaryimage"},"image":{"@id":"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/#primaryimage"},"thumbnailUrl":"https:\/\/ubc.com\/wp-content\/uploads\/2024\/06\/GettyImages-1141304089.jpg","datePublished":"2024-06-25T12:00:00+00:00","dateModified":"2025-05-15T21:38:02+00:00","description":"This augments the central site model with additional research services and tech to widen recruitment and improves site and patient experience.","breadcrumb":{"@id":"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/#primaryimage","url":"https:\/\/ubc.com\/wp-content\/uploads\/2024\/06\/GettyImages-1141304089.jpg","contentUrl":"https:\/\/ubc.com\/wp-content\/uploads\/2024\/06\/GettyImages-1141304089.jpg","width":2121,"height":1414,"caption":"Global network connection concept. Big data visualization. Social network communication in the global computer networks. Internet technology. Business. Science. Vector illustration."},{"@type":"BreadcrumbList","@id":"https:\/\/ubc.com\/news\/ubc-thread-expand-siteplus-optimize-evidence-generation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ubc.com\/"},{"@type":"ListItem","position":2,"name":"UBC and Thread Expand SitePlus Offering and Active Studies with BioPharma Sponsors to Optimize Evidence Generation"}]},{"@type":"WebSite","@id":"https:\/\/ubc.com\/#website","url":"https:\/\/ubc.com\/","name":"UBC","description":"","publisher":{"@id":"https:\/\/ubc.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ubc.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ubc.com\/#organization","name":"UBC","url":"https:\/\/ubc.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ubc.com\/#\/schema\/logo\/image\/","url":"https:\/\/ubc.com\/wp-content\/uploads\/2023\/07\/Layer_1.png","contentUrl":"https:\/\/ubc.com\/wp-content\/uploads\/2023\/07\/Layer_1.png","width":188,"height":50,"caption":"UBC"},"image":{"@id":"https:\/\/ubc.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ubc.com\/#\/schema\/person\/6c108e8902cd351f2e70ea0e7ba78b14","name":"HDMZ Dev","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ubc.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/da56f7401fb06d5e5f91ff06deaef82cd94d0acfef072f55663628117c7c4ac2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/da56f7401fb06d5e5f91ff06deaef82cd94d0acfef072f55663628117c7c4ac2?s=96&d=mm&r=g","caption":"HDMZ Dev"},"url":"https:\/\/ubc.com\/news\/author\/hdmzdev\/"}]}},"_links":{"self":[{"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/posts\/14152","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/comments?post=14152"}],"version-history":[{"count":3,"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/posts\/14152\/revisions"}],"predecessor-version":[{"id":15632,"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/posts\/14152\/revisions\/15632"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/media\/14153"}],"wp:attachment":[{"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/media?parent=14152"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/categories?post=14152"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/tags?post=14152"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}